Skip to main content

Table 2 Efficacy of vedolizumab

From: Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

 

Patients with clinical remission (%)

Patients with corticosteroid-free remission (%)

Patients with endoscopic remission (%)

 

Week 17 ± 0.5

1 year

Week 17 ± 0.5

1 year

Month 8.9 ± 0.7

UC

38/106 (36)

40/56 (71)

31/106 (29)

38/56 (68)

29/64 (45)

CD

26/75 (35)

16/25 (64)

22/75 (29)

14/25 (56)